Unknown

Dataset Information

Evaluation of hypoglycemic effect, safety and immunomodulation of Prevotella copri in mice.


ABSTRACT: The gut bacterium Prevotella copri (P. copri) has been shown to lower blood glucose levels in mice as well as in healthy humans, and is a promising candidate for a next generation probiotic aiming at prevention or treatment of obesity and type 2 diabetes. In this study the hypoglycemic effect of live P. copri was confirmed in mice and pasteurization of P. copri was shown to further enhance its capacity to improve glucose tolerance. The safety of live and pasteurized P. copri was evaluated by a 29-day oral toxicity study in mice. P. copri did not induce any adverse effects on body growth. General examination of the mice, gross pathological and histological analysis showed no abnormalities of the vital organs. Though relative liver weights were lower in the pasteurized (4.574 g ± 0.096) and

SUBMITTER: Verbrugghe P 

PROVIDER: S-EPMC8553810 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature